Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nextedia | ALNXT | 20. dec 2024 | 0.43 | +1.18 |
NFL Biosciences S.A. | ALNFL | 20. dec 2024 | 1.77 | -4.54 |
NHOA | NHOA | 20. dec 2024 | 1.24 | 0.00 |
Nicolas Miguet and Associes S.A | MLNMA | 20. dec 2024 | 0.07 | 0.00 |
Nicox SA | ALCOX | 20. dec 2024 | 0.29 | -0.68 |
Nokia | NOKIA | 20. dec 2024 | 4.21 | -1.25 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NBA | 20. dec 2024 | 5.90 | +3.51 |
Novacyt | ALNOV | 20. dec 2024 | 0.61 | -2.07 |
Novatech Industries | MLNOV | 20. dec 2024 | 10.50 | 0.00 |
NR 21 | NR21 | 20. dec 2024 | 32.00 | 0.00 |
NRJ Group | NRG | 20. dec 2024 | 7.00 | -1.41 |
NSC Groupe | ALNSC | 20. dec 2024 | 60.00 | +10.09 |
NSE SA | ALNSE | 20. dec 2024 | 28.40 | +0.35 |
Obiz | ALBIZ | 20. dec 2024 | 4.72 | +1.51 |
Odyssee Technologies S.A. | ALODY | 0.00 | 0.00 | |
Oeneo | SBT | 20. dec 2024 | 9.68 | +0.62 |
Omer-Decugis & Cie | ALODC | 20. dec 2024 | 4.11 | +1.99 |
Oncodesign Precision Medicine S.A | ALOPM | 20. dec 2024 | 0.89 | -8.44 |
One Experience | ALEXP | 20. dec 2024 | 0.31 | 0.00 |
Onlineformapro | MLONL | 20. dec 2024 | 1.60 | -11.11 |
OPmobility | OPM | 20. dec 2024 | 9.78 | -0.71 |
Orange. | ORA | 20. dec 2024 | 9.44 | -0.30 |
Orapi | ORAP | 20. dec 2024 | 6.50 | 0.00 |
Ordissimo | ALORD | 20. dec 2024 | 0.68 | +7.94 |
Orege | OREGE | 20. dec 2024 | 0.38 | +1.63 |
OSE Immunotherapeutics | OSE | 20. dec 2024 | 7.06 | -0.70 |
Osmosun S.A | ALWTR | 20. dec 2024 | 1.26 | -3.08 |
OVH GROUPE (PROM.)EO 1 | OVH | 20. dec 2024 | 8.46 | -0.06 |
Pacte Novation | MLPAC | 20. dec 2024 | 8.30 | 0.00 |
Paref | PAR | 20. dec 2024 | 38.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.